Влияние пандемии COVID-19 на устойчивое развитие фармацевтических компаний России

В настоящее время сложилось два мнения о пандемии COVID-19: она стала угрозой устойчивому экономическому развитию; основным бенефициаром ее последствий оказалась фармацевтическая промышленность. В статье проверяется истинность этих утверждений. Эмпирической базой исследования стали данные выборки, состоящей из 1771 предприятия фармацевтической промышленности России за период 2007—2020 гг. Использованы методы карт позиционирования и попарного сравнения финансовых показателей 2020 г. с двумя наиболее сильными кризисами в российской экономике (2009 и 2015 гг.), а также с периодом наиболее устойчивого развития (2007 г.) и доковидным годом (2019 г.). Для оценки равномерности влияния пандемии на участников отрасли были выделены аналитические группы по масштабам деятельности предприятий (микро-, малые, средние и крупные) и этапам жизненного цикла (молодые и зрелые фирмы). Сделан вывод о неравномерном влиянии пандемии на устойчивое развитие производителей в фармотрасли. Главными бенефициарами последствий пандемии оказались малые молодые компании. Наиболее сильно пострадали микропредприятия фармотрасли, однако пандемию нельзя считать основной причиной их неустойчивого развития. Кроме того, результаты исследования в целом свидетельствуют о наличии определенной стрессоустойчивости отечественных фармацевтических производств к кризисам различной природы.

1. DSM Group (2020). Фармацевтический рынок России 2020.

2. Балакин К. В., Айгинин А. А., Иващенко А. А. (2021). Российская фармацевтическая отрасль в горизонте 2030: Аналитический обзор. Долгопрудный: Биофармацевтический кластер «Северный».

3. Делойт (2017). Тренды фармацевтического рынка—2017. М.: Делойт и Туш СНГ.

4. Делойт (2020). Тренды фармацевтического рынка—2020. М.: Делойт и Туш СНГ.

5. Долгопятова Т. Г., Акиндинова Н. В., Симачев Ю. В., Яковлев. А. А. (ред.) (2021). Ответ российского бизнеса на пандемию COVID-19 (на примере шести отраслевых кейсов). М.: Изд. дом ВШЭ. С. 255—311.

6. Ивашковская И. В., Янгель Д. О. (2007). Жизненный цикл организации и агрегированный показатель роста // Корпоративные финансы. Т. 1, № 4. С. 97—110. https://doi.org/10.17323/j.jcfr.2073-0438.1.4.2007.97-110

7. Мамедьяров З. А. (2020). Стратегическое значение фармацевтической отрасли в условиях пандемии коронавируса // Международная аналитика. Т. 11, № 4. С. 122—136. https://doi.org/10.46272/2587-8476-2020-11-4-122-136

8. Ованесова Ю. С. (2013). Влияние стадии жизненного цикла организаций на эффективность IPO на развивающихся рынках капитала: дис. … канд. экон. наук. М.: НИУ ВШЭ.

9. Подшивалова М. В., Пылаева И. С., Алмршед С. К. (2021). Инновационный профиль предприятий фармацевтической отрасли России: «пациент скорее жив, чем мертв» // Вопросы экономики. № 6. С. 139—156. https://doi.org/10.32609/0042-8736-2021-6-139-156

10. Романова О. В., Авруцкая С. Г. (2021). Цифровые тренды в фармацевтической отрасли в период пандемии коронавируса // Успехи в химии и химической технологии. Т. 35, № 1. С. 59—61.

11. Росстат (2020). Российский статистический ежегодник. 2020: Стат. сб. М.: Федеральная служба государственной статистики.

12. Скороход А. Ю., Пахтусова В. Н. (2017). Жизненный цикл организации: модельный инструментарий идентификации стадии роста // Общество: политика, экономика, право. № 6. С. 41—46. https://doi.org/10.24158/pep.2017.6.10

13. Adizes I. (1989). Corporate lifecycles: How and why corporations grow and die and what to do about it. Englewood Cliffs, NJ: Prentice Hall.

14. Angell M. (2004). The truth about the drug companies. How they deceive us and what to do about it. New York: Random House.

15. Anthony J. H., Ramesh K. (1992). Association between accounting performance measures and stock prices: A test of the life cycle hypothesis. Journal of Accounting and Economics, Vol. 15, No. 2—3, pp. 203—227. https://doi.org/10.1016/0165-4101(92)90018-W

16. Ardito L., Petruzzelli A., Savino T. (2018). Maturity of knowledge inputs and innovation value: The moderating effect of firm age and size. Journal of Business Research, Vol. 86, pp. 190—201. https://doi.org/10.1016/j.jbusres.2018.02.009

17. Ayat M., Malikah Kang C. W. (2021). Effects of the COVID-19 pandemic on the construction sector: A systemized review. Engineering, Construction and Architectural Management. https://doi.org/10.1108/ECAM-08-2021-0704

18. Ayati N., Saiyarsarai P., Nikfar S. (2020). Short and long term impacts of COVID-19 on the pharmaceutical sector. DARU Journal of Pharmaceutical Sciences, Vol. 28, pp. 799—805. https://doi.org/10.1007/s40199-020-00358-5

19. Barman A., Das R., De P. K. (2021). Impact of COVID-19 in food supply chain: Disruptions and recovery strategy. Current Research in Behavioral Sciences, Vol. 2, pp. 1—5. https://doi.org/10.1016/j.crbeha.2021.100017

20. Beland L., Fakorede O., Mikola D. (2020). Canadian small businesses’ employees and owners during COVID-19. GLO Discussion Paper Series, No. 650. Global Labor Organization (GLO).

21. Caballero-Morales S.-O. (2021). Innovation as recovery strategy for SMEs in emerging economies during the COVID-19 pandemic. Research in International Business and Finance, Vol. 57, pp. 1—9. https://doi.org/10.1016/j.ribaf.2021.101396

22. Churchill N. C., Lewis V. (1983). The five stages of small business growth. Harvard Business Review, May—June, pp. 1—11.

23. Coudeville L., Gomez G. B., Jollivet O., Harris R. C., Thommes E., Druelles S., Chit A., Chaves S. S., Mahé C. (2020). Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry. Vaccine, Vol. 38, No. 48, pp. 7588—7595. https://doi.org/doi:10.1016/j.vaccine.2020.10.034

24. Cowling M., Liu W., Zhang N. (2018). Did firm age, experience, and access to finance count? SME performance after the global financial crisis. Journal of Evolutionary Economics, Vol. 28, No. 1, pp. 77—100. https://doi.org/10.1007/s00191-017-0502-z

25. Dai R., Feng H., Hu J., Jin Q., Li H., Wang R., Wang R., Xu L., Zhang X. (2021). The impact of COVID-19 on small and medium-sized enterprises (SMEs): Evidence from two-wave phone surveys in China. China Economic Review, Vol. 67, pp. 1—20. https://doi.org/10.1016/j.chieco.2021.101607

26. Das S., Kundu A., Bhattacharya A. (2020). Technology adaptation and survival of SMEs: A longitudinal study of developing countries. Technology Innovation Management Review, Vol. 10, No. 6, pp. 64—72. https://doi.org/10.22215/timreview/1369

27. Davis J., Edgar T., Porter J., Bernaden J., Sarli M. (2012). Smart manufacturing, manufacturing intelligence and demand-dynamic performance. Computers & Chemical Engineering, Vol. 47, pp. 145—156. https://doi.org/10.1016/j.compchemeng.2012.06.037

28. Derqui B., Filimonau V., Matute J. (2021). Assessing the scale of adoption of sustainability practices by community pharmacies in Spain in the time of COVID-19. Sustainable Production and Consumption, Vol. 27, pp. 1626—1636. https://doi.org/10.1016/j.spc.2021.03.034

29. Dickinson V. (2011). Cash flow patterns as a proxy for firm life cycle. Accounting Review, Vol. 86, No. 6, pp. 1969—1994. https://doi.org/10.2308/accr-10130

30. Eggers F., Hansen D. J., Davis A. E. (2012). Examining the relationship between customer and entrepreneurial orientation on nascent firms’ marketing strategy. International Entrepreneurship and Management Journal, Vol. 8, No. 2, pp. 203—222. https://doi.org/10.1007/s11365-011-0173-4

31. Greiner L. (1972). Evolution and revolution as organizations grow. Harvard Business Review, Vol. 50, No. 4, pp. 37—46.

32. Hanks S. H., Watson C. J., Jansen E., Chandler G. N. (1993). Tightening the lifecycle construct: A taxonomic study of growth stage configurations in high technology organizations. Entrepreneurship Theory and Practice, Vol. 12, No. 2, pp. 5—30. https://doi.org/10.1177/104225879401800201

33. Heidenreich M. (2009). Innovation patterns and location of European low- and mediumtechnology industries. Research Policy, Vol. 38, No. 3, pp. 483—494. https://doi.org/10.1016/j.respol.2008.10.005

34. Hervas-Oliver J.-L., Sempere-Ripoll F., Boronat-Moll C. (2021). Technological innovation typologies and open innovation in SMEs: Beyond internal and external sources of knowledge. Technological Forecasting and Social Change, Vol. 162, No. C, article 120338. https://doi.org/10.1016/j.techfore.2020.120338

35. Hirsch-Kreinsen H. (2016). Digitization of industrial work: Development paths and prospects. Journal for Labour Market Research, Vol. 49, No. 1, pp. 1—14.

36. Jackson J. K., Weiss M. A., Schwarzenberg A. B., Nelson R. M., Sutter K. M., Sutherland M. D. (2021). Global economic effects of COVID-19. Washington, DC: Congressional Research Service.

37. Karlsson C., Olsson O. (1998). Product innovation in small and large enterprises. Small Business Economics, Vol. 10, pp. 31—46. https://doi.org/10.1023/A:1007970416484

38. Kneller R. (2010). The importance of new companies for drug discovery: Origins of a decade of new drugs. Nature Reviews Drug Discovery, Vol. 9, pp. 867—882. https://doi.org/10.1038/nrd3251

39. Kowalkowski C., Witell L., Gustafsson A. (2013). Any way goes: Identifying value constellations for service infusion in SMEs. Industrial Marketing Management, Vol. 42, No. 1, pp. 18—30. https://doi.org/10.1016/j.indmarman.2012.11.004

40. Lee J., Bagheri B., Kao H.-A. (2014). Recent advances and trends of cyber-physical systems and big data analytics in industrial informatics. Proceeding of International Conference on Industrial Informatics (INDIN), pp. 1—6. https://doi.org/10.13140/2.1.1464.1920

41. Lefebvre L.-A., Lefebvre E., Colin D. (2009). Process innovation, productivity, and competitiveness in smaller manufacturing firms. Canadian Journal of Administrative Sciences, Vol. 8, No. 1, pp. 19—28. https://doi.org/10.1111/j.1936-4490.1991.tb00659.x

42. Lim S. H. (2021). Promissory shock, broken future: COVID-19 and state-led speculations in biotechnology and pharmaceutical industries in South Korea. Applied Geography, Vol. 136, article 102560. https://doi.org/10.1016/j.apgeog.2021.102560

43. Miller D., Friesen P. H. (1984). A longitudinal study of the corporate life cycle. Managerial Science, Vol. 30, pp. 1161—1183. https://doi.org/10.1287/mnsc.30.10.1161

44. Mishra N. P., Das S. S., Yadav S., Khan W., Afzal M., Alarifi A., … Nayak A. K. (2020). Global impacts of pre- and post-COVID-19 pandemic: Focus on socioeconomic consequences. Sensors International, Vol. 1, article 100042. https://doi.org/10.1016/j.sintl.2020.100042

45. Morck R., Yeung B. (2001). The economic determinants of innovation. Industry Canada Occasional Paper, No. 25.

46. Munos B. H. (2009). Lessons from 60 years of pharmaceutical innovation. Nature Review Drug Discovery, Vol. 8, pp. 959—968. https://doi.org/10.1038/nrd2961

47. Nieminen J. (2019). Innovation maturity matrix — A model to successful innovation transformation. Viima, November 1. https://www.viima.com/blog/innovationmaturity-matrix

48. OECD (2020). The impact of COVID-19 on SME financing: A special edition of the OECD Financing SMEs and Entrepreneurs Scoreboard. OECD SME and Entrepreneurship Papers, No. 22. Paris: OECD Publishing. https://doi.org/10.1787/ecd81a65-en

49. Patel P., Arundel A., Hopkins M. M. (2008). Sectoral innovation systems in Europe: Monitoring, analysing trends and identifying challenges in biotechnology. Brighton: SPRU, University of Sussex.

50. Pellegrino G., Piva M., Vivarelli M. (2009). How do young companies innovate? Discussion Paper IZA DP, No. 4301. https://doi.org/10.2139/ssrn.1439154

51. Persson H. (2004). The survival and growth of new establishments in Sweden, 1987—1995. Small Business Economics, Vol. 23, No. 5, pp. 423—440. https://doi.org/10.1007/s11187-004-3992-7

52. Powell W.W., Koput K.W., Smith-Doerr L. (1996). Interorganizational collaboration and the locus of innovation: Networks of learning in biotechnology. Administrative Science Quarterly, Vol. 41, pp. 116—145. https://doi.org/10.2307/2393988

53. Queiroz M. M., Ivanov D., Dolgui A., Fosso Wamba S. (2020). Impacts of epidemic outbreaks on supply chains: Mapping a research agenda amid the COVID-19 pandemic through a structured literature review. Annals of Operations Research, pp. 1—38. https://doi.org/10.1007/s10479-020-03685-7

54. Rafols I., Hopkins M. M., Hoekman J., Siepel J., O’Hare A., Perianes Rodríguez A., Nightingale P. (2014). Big Pharma, little science? A bibliometric perspective on big pharma’s R&D decline. Technological Forecasting and Social Change, Vol. 81, pp. 22—38. https://doi.org/10.1016/j.techfore.2012.06.007

55. Raymond L., St-Pierre J. (2010). R&D as a determinant of innovation in manufacturing SMEs: An attempt at empirical clarification. Technovation, Vol. 30, No. 1, pp. 48—56. https://doi.org/10.1016/j.technovation.2009.05.005

56. Schuhmacher A., Gatto A., Kuss M., Gassmann O., Hinder M. (2021). Big Techs and startups in pharmaceutical R&D — A 2020 perspective on artificial intelligence. Drug Discovery Today, Vol. 26, No. 10, pp. 2226—2231. https://doi.org/10.1016/j.drudis.2021.04.028

57. Sen S., Antara N., Sen S., Chowdhury S. (2020). The unprecedented pandemic ‘COVID-19’ effect on the apparel workers by shivering the apparel supply chain. Journal of Textile and Apparel, Technology and Management, Vol. 11, No. 3, pp. 1—20. https://doi.org/10.2139/ssrn.3598542

58. Shin S.-J., Woo J., Rachuri S. (2014). Predictive analytics model for power consumption in manufacturing. Procedia CIRP, Vol. 15, pp. 153—158. https://doi.org/10.1016/j.procir.2014.06.036

59. Simón-Moya V., Revuelto-Taboada L., Ribeiro-Soriano D. (2016). Influence of economic crisis on new SME survival: Reality or fiction? Entrepreneurship & Regional Development, Vol. 28, No. 1—2, pp. 157—176. https://doi.org/10.1080/08985626.2015.1118560

60. Slack N., Lewis M. (2014). Operations strategy. 4th ed. Prentice Hall.

61. Stinchcombe A. L. (1965). Social structure and organizations. In: J. G. March (ed.). Handbook of organizations. Chicago: Rand McNally, pp. 142—193.

62. Subramanian R., Toney J. H., Jayachandran C. (2011). The evolution of research and development in the pharmaceutical industry: Toward the open innovation model — can pharma reinvent itself? International Journal of Business Innovation and Research, Vol. 5, pp. 63—74. https://doi.org/10.1504/IJBIR.2011.037257

63. Thorgren S., Williams T. A. (2020). Staying alive during an unfolding crisis: How SMEs ward off impending disaster. Journal of Business Venturing Insights, Vol. 14, article e00187. https://doi.org/10.1016/j.jbvi.2020.e00187

64. Tirivangani T., Alpo B., Kibuule D., Gaeseb J., Adenuga B. A. (2021). Impact of COVID-19 pandemic on pharmaceutical systems and supply chain — a phenomenological study. Exploratory Research in Clinical and Social Pharmacy, Vol. 2, article 100037. https://doi.org/10.1016/j.rcsop.2021.100037

65. Török Á., Tóth J., Máté Balogh J. (2018). Push or pull? The nature of innovation process in the Hungarian food SMEs. Journal of Innovation & Knowledge, Vol. 4, No. 4, pp. 234—239. https://doi.org/10.1016/j.jik.2018.03.007

66. Vaisman E. D., Podshivalova M. V., Alola A. A. (2022). Examining the interaction of sustainable innovation activity and the life cycle of small high-tech enterprises. Business Strategy and the Environment, Vol. 31, No. 3, pp. 1018—1029. https://doi.org/10.1002/bse.2932

67. WCED (1987). Our common future. World Commission on Environment and Development. New York: Oxford University Press.

68. Wellalage N. H., Fernandez V. (2019). Innovation and SME finance: Evidence from developing countries. International Review of Financial Analysis, Vol. 66, No. C. https://doi.org/10.1016/j.irfa.2019.06.009

69. Xu Z., Elomri A., Kerbache L., El Omri A. (2020). Impacts of COVID-19 on global supply chains: Facts and perspectives. IEEE Engineering Management Review, Vol. 48, No. 3, pp. 153—166. https://doi.org/10.1109/EMR.2020.3018420

70. Yu D. E. C., Razon L. F., Tan R. R. (2020). Can global pharmaceutical supply chains scale up sustainably for the covid-19 crisis? Resources, Conservation and Recycling, Vol. 159, article 104868. https://doi.org/10.1016/j.resconrec.2020.104868

71. Zhang Y., Zhang G., Wang J., Sun S., Si S., Yang T. (2014). Real-time information capturing and integration framework of the internet of manufacturing things. International Journal of Computer Integrated Manufacturing, Vol. 28, No. 8, pp. 811—822. https://doi.org/10.1080/0951192X.2014.900874

72. Zhu W., Zhang P., Wang Z. (2020). Firm crisis, government support and policy efficiency under the pandemic shock: Evidence from two waves of questionnaire on SMEs. Management World, Vol. 36, No. 4, pp. 13—26.